Company Performance - Universal Health Services (UHS) shares have increased by 19.9% over the past month, reaching a new 52-week high of $221.66 [1] - The stock has gained 44.6% since the beginning of the year, outperforming the Zacks Medical sector's 8.2% and the Zacks Medical - Hospital industry's 37.5% [1] Earnings and Revenue - UHS has a strong record of positive earnings surprises, not missing earnings consensus estimates in the last four quarters [2] - In the latest earnings report on July 24, 2024, UHS reported EPS of $4.31, exceeding the consensus estimate of $3.37 [2] - For the current fiscal year, UHS is expected to post earnings of $15.61 per share on revenues of $15.66 billion, reflecting a 48.1% change in EPS and a 9.67% change in revenues [3] - For the next fiscal year, earnings are projected at $17.09 per share on revenues of $16.52 billion, indicating year-over-year changes of 9.49% and 5.47%, respectively [3] Valuation Metrics - UHS currently trades at 14.1X current fiscal year EPS estimates, below the peer industry average of 15.8X [7] - On a trailing cash flow basis, UHS trades at 11.3X compared to the peer group's average of 11.6X [7] - The stock has a PEG ratio of 0.74, which does not place it among the top echelon of stocks from a value perspective [7] Zacks Rank and Style Scores - UHS holds a Zacks Rank of 1 (Strong Buy) due to favorable earnings estimate revisions from analysts [8] - The stock has a Value Score of A, a Growth Score of A, and a Momentum Score of C, resulting in a combined VGM Score of A [6] Industry Comparison - Tenet Healthcare Corporation (THC) is a notable peer with a Zacks Rank of 1 (Strong Buy) and a Value Score of A, indicating strong performance within the industry [10] - THC is expected to post earnings of $10.44 per share on revenues of $20.84 billion for the current fiscal year, having beaten consensus estimates by 22.22% last quarter [11] - The Medical - Hospital industry is in the top 2% of all industries, suggesting favorable conditions for both UHS and THC [12]

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time. Everyone likes betting on fast-moving trending stocks, but it isn't easy to determine the right entry point. These stocks often lose momentum when their future growth potential fails to justify their swelled-up valuation. In that phas ...

Universal Health Services (UHS) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company. The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annua ...

Momentum Investing Overview - Momentum investing focuses on following a stock's recent trend, aiming to buy high and sell even higher [1] - The strategy relies on identifying stocks that are likely to continue moving in their current direction [1] Universal Health Services (UHS) Performance - UHS shares have risen 18.18% over the past week, outperforming the Zacks Medical - Hospital industry's 10.13% gain [2] - Over the past month, UHS shares have increased by 15.55%, compared to the industry's 10.43% performance [2] - UHS has seen a 27.42% rise over the past quarter and a 54.02% increase over the last year, significantly outperforming the S&P 500's 7.48% and 21.12% gains, respectively [8] Trading Volume and Momentum Indicators - UHS has an average 20-day trading volume of 816,389 shares, which is a useful indicator for establishing price-to-volume baselines [3] - A rising stock with above-average volume is generally considered a bullish sign [3] Earnings Estimate Revisions - Over the past two months, 3 earnings estimates for UHS have moved higher compared to 1 lower for the full year, boosting the consensus estimate from $13.64 to $14.19 [13] - For the next fiscal year, 3 estimates have moved upwards with no downward revisions in the same period [13] Zacks Rank and Momentum Style Score - UHS currently holds a Zacks Rank of 2 (Buy) and a Momentum Style Score of A, indicating strong potential for outperformance [6][14] - Stocks with Zacks Rank 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B tend to outperform the market over the following one-month period [6] Industry Comparison and Momentum Metrics - Comparing a stock's short-term price activity to its industry can help identify top companies in a particular sector [7] - Longer-term price metrics, such as performance over the last three months or year, are also advantageous for evaluating momentum [8]

The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on July 24, 2024, Universal Health Services reported EPS of $4.31 versus consensus estimate of $3.37. Universal Health Services may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback ...

Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead of their future growth potential. In such a situation, investors find themselves loaded up on expensive shares with limited to no upside or even a downside. So, going all-in on momentum could be risky at times. There are several stocks that currently pass through the screen and Universal Health Services (UHS) is one of them. Here are th ...

Universal Health Services, Inc. (NYSE:UHS) Q2 2024 Earnings Conference Call July 25, 2024 9:00 AM ET Company Participants Steve Filton - Executive Vice President & Chief Financial Officer Marc Miller - President & Chief Executive Officer Conference Call Participants Ann Hynes - Mizuho Securities Stephen Baxter - Wells Fargo Ben Hendrix - RBC Capital Markets A.J. Rice - UBS Justin Lake - Wolfe Research Jason Cassorla - Citi Sarah James - Cantor Fitzgerald Andrew Mok - Barclays Pito Chickering - Deutsche Bank ...

Share Repurchase Update Adjusted EBITDA, net of NCI, is now estimated to be in the range of $2.154-$2.226 billion. The midpoint of the guidance suggests a 25.7% improvement from the 2023 figure. UHS increased its adjusted EPS guidance in the range of $15.4-$16.2. The midpoint of the forecast indicates a rise of 49.9% from the 2023 figure. Other Medical Sector Releases HCA Healthcare reported second-quarter 2024 adjusted EPS of $5.50, which beat the Zacks Consensus Estimate by 10.7%. The bottom line improved ...

FOR IMMEDIATE RELEASE July 24, 2024 CONTACT: Steve Filton Chief Financial Officer 610-768-3300 UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2024 SECOND QUARTER FINANCIAL RESULTS, INCREASES 2024 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended June 30, 2024 and 2023: KING OF PRUSSIA, PA – Universal Health Services, Inc. (NYSE: UHS) announced today that its r ...

The reported revenue represents a surprise of +1.52% over the Zacks Consensus Estimate of $3.85 billion. With the consensus EPS estimate being $3.37, the EPS surprise was +27.89%. Here is how Universal Health Services performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price pe ...